These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7572394)

  • 1. Inhibition of T lymphocyte activation and apoptotic cell death by cyclosporin A and tacrolimus (FK506). Its relevance to therapy of HIV infection.
    Thomson AW; Bonham CA
    Adv Exp Med Biol; 1995; 374():211-6. PubMed ID: 7572394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506.
    Brunner T; Yoo NJ; LaFace D; Ware CF; Green DR
    Int Immunol; 1996 Jul; 8(7):1017-26. PubMed ID: 8757947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and biological actions of cyclosporin A and FK506 on T cell development and function.
    Holländer GA; Bierer BE; Burakoff SJ
    Transfus Sci; 1994 Sep; 15(3):207-20. PubMed ID: 10155542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis.
    Koenen HJ; Michielsen EC; Verstappen J; Fasse E; Joosten I
    Transplantation; 2003 May; 75(9):1581-90. PubMed ID: 12792519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of two immunosuppressive drugs, cyclosporin A and tacrolimus, to inhibit virus replication and apoptosis in cells infected with feline immunodeficiency virus.
    Mortola E; Endo Y; Ohno K; Watari T; Tsujimoto H; Hasegawa A
    Vet Res Commun; 1998 Dec; 22(8):553-63. PubMed ID: 10066129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs.
    Strauss G; Osen W; Debatin KM
    Clin Exp Immunol; 2002 May; 128(2):255-66. PubMed ID: 11985515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506.
    Karpas A; Lowdell M; Jacobson SK; Hill F
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8351-5. PubMed ID: 1381509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin a inhibits calcineurin/nuclear factor of activated T-cells signaling and induces apoptosis in retinoblastoma cells.
    Eckstein LA; Van Quill KR; Bui SK; Uusitalo MS; O'Brien JM
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):782-90. PubMed ID: 15728531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The actions of cyclosporin A and FK506 on T-lymphocyte activation.
    Mattila PS
    Biochem Soc Trans; 1996 Feb; 24(1):45-9. PubMed ID: 8674715
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine A- and FK506-induced apoptosis in PC12 cells.
    Takadera T; Sakamoto Y; Hizume Y; Ohyashiki T
    Cell Biol Toxicol; 2007 Sep; 23(5):355-60. PubMed ID: 17385075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of immunosuppressive drugs on the regulation of activation-induced apoptotic cell death in thymocytes.
    McCarthy SA; Cacchione RN; Mainwaring MS; Cairns JS
    Transplantation; 1992 Sep; 54(3):543-7. PubMed ID: 1384186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells.
    Cho CS; Chang Z; Elkahwaji J; Scheunemann TL; Manthei ER; Colburn M; Knechtle SJ; Hamawy MM
    Int Immunol; 2003 Nov; 15(11):1369-78. PubMed ID: 14565935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1, NFAT, and cyclosporin: immunosuppression for the immunosuppressed?
    Cron RQ
    DNA Cell Biol; 2001 Dec; 20(12):761-7. PubMed ID: 11879569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modes of action of FK506, cyclosporin A, and rapamycin.
    Morris R
    Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent advances in the mechanism of action of cyclosporine and FK506.
    Tocci MJ; Sigal NH
    Curr Opin Nephrol Hypertens; 1992 Dec; 1(2):236-42. PubMed ID: 1285380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of cyclosporin A and FK506 from nitric oxide-dependent apoptosis in activated macrophages.
    Hortelano S; López-Collazo E; Boscá L
    Br J Pharmacol; 1999 Mar; 126(5):1139-46. PubMed ID: 10205001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
    Hess DA; Bird IA; Almawi WY; Rieder MJ
    J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A but not FK506 inhibits thyroid hormone-induced apoptosis in tadpole intestinal epithelium.
    Su Y; Shi Y; Shi YB
    FASEB J; 1997 Jun; 11(7):559-65. PubMed ID: 9212079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FK506 augments activation-induced programmed cell death of T lymphocytes in vivo.
    Migita K; Eguchi K; Kawabe Y; Tsukada T; Mizokami A; Nagataki S
    J Clin Invest; 1995 Aug; 96(2):727-32. PubMed ID: 7543492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte-sensitivity to glucocorticoid correlates with the sensitivity to cyclosporin A and tacrolimus in chronic renal failure patients.
    Horigome A; Hirano T; Oka K; Takeuchi H; Sakurai E; Kozaki K; Matsuno N; Nagao T; Kozaki M
    Br J Clin Pharmacol; 1999 Oct; 48(4):573-8. PubMed ID: 10583028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.